title: Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence.
authors.forename: Fred Arthur
authors.initials: FA
authors.lastname: Zar
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D000077732:Fidaxomicin; D006801:Humans; D021141:Nucleic Acid Amplification Techniques; D055502:Secondary Prevention; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000077732:Fidaxomicin